Nanalysis Scientific Balance Sheet Health
Financial Health criteria checks 2/6
Nanalysis Scientific has a total shareholder equity of CA$24.2M and total debt of CA$14.7M, which brings its debt-to-equity ratio to 61%. Its total assets and total liabilities are CA$51.5M and CA$27.3M respectively.
Key information
61.0%
Debt to equity ratio
CA$14.75m
Debt
| Interest coverage ratio | n/a |
| Cash | CA$1.13m |
| Equity | CA$24.17m |
| Total liabilities | CA$27.29m |
| Total assets | CA$51.45m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NSCI.F's short term assets (CA$17.7M) exceed its short term liabilities (CA$12.5M).
Long Term Liabilities: NSCI.F's short term assets (CA$17.7M) exceed its long term liabilities (CA$14.8M).
Debt to Equity History and Analysis
Debt Level: NSCI.F's net debt to equity ratio (56.4%) is considered high.
Reducing Debt: NSCI.F's debt to equity ratio has increased from 7.6% to 61% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NSCI.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NSCI.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 37.8% each year